deficiency 1-5 . So far, p21 is the only p53 target shown to contribute to p53 repression of iPSC (induced pluripotent stem cell) generation 1,3 , indicating that additional p53 targets may regulate this process. Here, we demonstrate that miR-34 microRNAs (miRNAs), particularly miR-34a, exhibit p53-dependent induction during reprogramming. Mir34a deficiency in mice significantly increased reprogramming efficiency and kinetics, with miR-34a and p21 cooperatively regulating somatic reprogramming downstream of p53. Unlike p53 deficiency, which enhances reprogramming at the expense of iPSC pluripotency, genetic ablation of Mir34a promoted iPSC generation without compromising self-renewal or differentiation. Suppression of reprogramming by miR-34a was due, at least in part, to repression of pluripotency genes, including Nanog, Sox2 and Mycn (also known as N-Myc ). This post-transcriptional gene repression by miR-34a also regulated iPSC differentiation kinetics. miR-34b and c similarly repressed reprogramming; and all three miR-34 miRNAs acted cooperatively in this process. Taken together, our findings identified miR-34 miRNAs as p53 targets that play an essential role in restraining somatic reprogramming.
generates iPSCs with low efficiency and slow kinetics, suggesting the existence of cellular and molecular barriers to the process 10 .
Recent studies have revealed considerable mechanistic overlap between somatic cell reprogramming and malignant transformation 11 . Cellular mechanisms that enhance reprogramming, including cell proliferation and survival, evasion of DNA-damage response, and cell immortalization, have long been known to promote tumorigenesis [3] [4] [5] 12 . Several oncogenes and tumour suppressors also serve as essential regulators for reprogramming 6, 10, 11 . Notably, the inactivation of p53, one of the most important tumour suppressors, significantly enhances iPSC generation [1] [2] [3] [4] [5] 13 . As a tumour suppressor, p53's transcriptional regulation converges onto multiple target genes that collectively mediate its downstream effects, including cell-cycle arrest, cellular senescence, apoptosis, DNA-damage response and genomic stability 14 . Similarly, p53's role in repressing reprogramming is probably also mediated through multiple targets. To date, the cell-cycle regulator p21 is the only p53 target with a demonstrated role in repressing reprogramming. However, p21 deficiency only partially phenocopies that of p53 (refs 1,3,15) , suggesting that p53 represses iPSC generation through as-yet unidentified mechanism(s) and target(s).
Previous studies have identified the miR-34 microRNAs (miRNAs) as bona fide p53 transcriptional targets, whose overexpression triggers cell-cycle arrest or apoptosis in a cell-type-and contextdependent manner [16] [17] [18] . miRNAs, a large family of small non-coding RNAs, primarily repress gene expression post-transcriptionally, by pairing with partially complementary messenger RNA targets 19, 20 . In response to p53 activation, induced Mir34 miRNAs can mediate p53 downstream effects by repressing specific target genes, including cyclin D1, cyclin E2, Cdk4, Cdk6, Bcl2 and c-Met (ref. 21) . Although p53 is primarily characterized for its role in transcriptional activation, it acts as a global gene regulator that both activates and represses gene expression 14 . Direct transcriptional repression, together with indirect post-transcriptional repression through miRNAs such as miR-34, constitute two major mechanisms for p53mediated gene repression.
The miR-34 miRNAs belong to an evolutionarily conserved family, with three mammalian homologues, miR-34a, b and c, localized to two distinct genomic loci, Mir34a and Mir34b/c (Fig. 1a ; ref. 16 ). All three Mir34 miRNAs were significantly induced when mouse embryonic fibroblast (MEF) reprogramming was triggered with Sox2, Oct4 and Klf4 in the presence or absence of c-Myc ( Fig. 2a , data not shown). In both cases, Mir34 induction, similarly to that of p21, was dependent on the activation of intact p53 ( Fig. 2a ). We therefore investigated whether miR-34 miRNAs are components of the reprogramming regulatory circuit downstream of p53. Among all miR-34 miRNAs, miR-34a exhibited the highest induction level during reprogramming, whereas miR-34b was the lowest. We therefore focused initially on the role of Mir34a in iPSC induction.
We generated Mir34a knockout mice using C57BL/6 ESCs (Fig. 1a ), confirmed the germline transmission of the targeted allele ( Fig. 1b ) and verified the genetic ablation of Mir34a by expression studies (Fig. 1c ). Mir34a −/− mice were born at the expected Mendelian ratio, without obvious developmental or pathological abnormalities up to 12 months. However, when we induced the Mir34a −/− MEFs for reprogramming, we observed a significant increase in the reprogramming efficiency (Fig. 2b,d and Supplementary Fig. S1a ). Three-factor-infected Mir34a −/− MEFs exhibited a ∼4.5-fold increase in alkaline phosphatase-positive colonies with typical iPSC morphology ( Fig. 2b) , whereas four-factor-infected Mir34a −/− MEFs yielded a ∼4-fold increase ( Supplementary Fig. S1a ). Furthermore, when we plated infected MEFs into 96-well plates at a density of one cell per well, Mir34a deficiency caused a similar increase in alkaline phosphatase-positive colonies with typical iPSC morphology ( Fig. 2c ).
Using MEFs carrying an Oct4-Gfp knockin reporter allele 22 , we confirmed the effect of miR-34a in promoting reprogramming, scoring fully reprogrammed iPSCs on the basis of endogenous Oct4 expression indicated by green fluorescent protein (GFP). Consistently, a greater than fourfold increase in reprogramming efficiency was observed in Mir34a −/− ; Oct 4-Gfp/+ MEFs after three-or four-factor transduction ( Fig. 2d ). A significant increase in reprogramed Oct4-Gfp-positive colonies could also be achieved using a locked nucleic acid (LNA) inhibitor against miR-34a ( Supplementary Fig. S1b ). Notably, Mir34a deficiency both enhanced the overall efficiency of iPSC generation and led to more rapid reprogramming kinetics. Small iPSC-like colonies first appeared 7 days post-infection in four-factor-transduced wild-type MEFs, but as early as post-infection day 5 in Mir34a −/− MEFs.
As miR-34b and c share the miR-34a seed sequence and are similarly induced during reprogramming ( Fig. 2a ), they probably also regulate iPSC generation. We generated Mir34b/c knockout mice ( Fig. 1a-c) . As with miR-34a deficiency, Mir34b/c knockout alone promoted somatic reprogramming, although to a lesser degree ( Fig. 2e ). Interestingly, MEFs deficient for all three miR-34 miRNAs exhibited an even greater increase in iPSC generation ( Fig. 2e ), suggesting a cooperative effect among these genes, although the exact molecular and cellular mechanisms underlying this cooperation still remained unclear. As the Mir34a −/− ; Mir34b/c −/− MEFs did not completely phenocopy p53 −/− MEFs, extra mechanisms may act downstream of p53 to mediate the suppression of reprogramming.
Previous studies have identified p21 as an important mediator of p53 suppression of reprogramming 1, 12 . Mir34 and p21 both exhibited p53-dependent induction during reprogramming ( Fig. 2a ). p21 induction also was observed in Mir34a −/− MEFs (Fig. 3a) . Whereas MEFs deficient for Mir34a alone or p21 alone showed comparable increases in iPSC generation, MEFs deficient for both Mir34a and p21 exhibited a cooperative increase that recapitulated a significant fraction of the p53 effect ( Fig. 3c ). Given the functional similarities among the three miR-34 miRNAs, the cooperative effects among p21 and all miR-34 miRNAs could be even greater. Thus, the miR-34 miRNAs, together with p21, constitute important downstream effectors of p53 to mediate the repression of reprogramming.
p21 represses reprogramming efficiency primarily through its repression of cell proliferation 12 . Although miR-34a and p21 repress reprogramming efficiency similarly ( Fig. 3c) , their effects on cell proliferation are quite different. The increased cell proliferation in p21 −/− MEFs was highly significant (Fig. 3b ), yet within the time frame of our reprogramming experiments Mir34a −/− MEFs exhibited little increase up to passage 6. We cannot completely exclude the possibility that a mild increase in Mir34a −/− MEF proliferation contributed to the increased reprogramming. Yet, unlike p21, whose effects on reprogramming are largely attributed to its inhibition of cell proliferation 12 , miR-34a is likely to act mostly through a separate mechanism independent of cell proliferation. These two distinct mechanisms may underlie the cooperative regulation of reprogramming by miR-34a and p21.
Mir34a −/− iPSCs resemble wild-type iPSCs and ESCs, exhibiting ESC-like morphology ( Fig. 4a and Supplementary Fig. S1c ) and expressing key molecular markers for pluripotency. High levels of Oct4, Nanog and SSEA1 were detected ( Fig. 4b and Supplementary Fig. S1d ). Mir34a −/− iPSCs injected into immunocompromised nude mice yielded differentiated teratomas, containing terminally differentiated cell types from all three germ layers ( Fig. 4c,d and Supplementary  Fig. S1e ). Furthermore, three independent lines of four-factor-induced Mir34a −/− iPSCs all yielded healthy adult chimaeric mice with a high percentage of iPSC contribution ( Fig. 4e and Supplementary Fig. S1g , Table S1 ). Taken together, Mir34a deficiency enhances the efficiency of iPSC generation without compromising self-renewal or pluripotency.
Although p53 deficiency induced reprogramming more efficiently than Mir34a deficiency, the p53 −/− iPSCs exhibited compromised self-renewal and differentiation capacity 1, 4 . As also reported in ref. 1, we have observed that four-factor-induced p53 −/− iPSCs lost ESC-like morphology after five to six passages in culture, and failed to generate highly differentiated teratomas. In contrast, four-factor-induced Mir34a −/− iPSCs remained stable beyond passage 26, with no significant differences in self-renewal when compared with wild-type iPSCs ( Supplementary Fig. S1f ). Furthermore, generation of healthy adult chimaeras from p53 −/− iPSCs was difficult. The percentage of p53 −/− iPSC contribution was low, and the majority of such chimaeras succumbed to tumorigenesis before 7 weeks 1 . In contrast, Mir34a −/− iPSCs exhibited functional pluripotency: all three four-factor-induced Mir34a −/− iPSC lines tested gave rise to healthy adult chimaeras with a high percentage of iPSC contribution ( Fig. 4e and Supplementary S1g, Table S1 ), which remained tumour free for 6 months (to the time of manuscript preparation). Consistent with these differences, we observed that four-factorinduced p53 −/− iPSCs, but not Mir34a −/− or wild-type iPSCs, failed to silence retroviral transgenes, thus exhibiting lower levels of the corresponding endogenous genes ( Supplementary Fig. S3a -c). The exogenous expression of reprogramming factors, particularly c-Myc ( Supplementary Fig. S3e ), may contribute to the impaired self-renewal and differentiation ( Supplementary Fig. S3d ), and promote tumorigenesis 1 . In contrast, pluripotency was established easily in Mir34a −/− iPSCs by the endogenous transcription factor circuitry, leaving the exogenous transgenes dispensable for the maintenance of pluripotency.
Similar to Mir34a −/− iPSCs, Mir34a −/− ; Mir34b/c −/− iPSCs also exhibited robust self-renewal and differentiation capacity, with typical ESC morphology, key pluripotency markers and the ability to generate differentiated teratomas ( Supplementary Fig. S2a -c). Their ability to generate chimaeras remains to be determined.
The increased reprogramming efficiency and compromised pluripotency of p53 −/− MEFs may result from aberrant apoptosis and DNA damage response 4 . However, Mir34a deficiency failed to protect cells from apoptosis or DNA-damage response during reprogramming ( Supplementary Fig. S4a-c) . Thus, the enhanced reprogramming efficiency observed in Mir34a −/− MEFs may reflect a mechanism largely independent of apoptosis and DNA damage response. These findings contrast with the ability of Mir34a overexpression to trigger apoptosis in specific tumour cells 17, 18 . These Mir34a effects on apoptosis are probably cell-type dependent, differing between primary fibroblasts 16 and specific cancer cell lines 17, 18 . Cells deficient for Mir34a may exhibit apoptotic defects under conditions other than reprogramming. It is also possible that the lack of apoptotic protection in reprogramming Mir34a −/− MEFs reflects the functional redundancy of miR-34b and c.
Enhanced reprogramming in p53-deficient cells has also been attributed to cell immortalization and increased cell proliferation [1] [2] [3] [4] [5] 12, 15 . Whereas cell immortalization greatly promotes iPSC generation from p53 −/− MEFs (ref. 5), increased cell proliferation is a key mechanism driving stochastic reprogramming of p53 KD B cells 12 . Although Mir34 overexpression induced growth arrest and cellular senescence in primary fibroblasts 16 , no defects in senescence response were observed in Mir34a −/− MEFs during reprogramming ( Supplementary Fig. S4d and data not shown). As described above, we did not observe a significant MEF proliferation difference caused by Mir34a deletion within the time frame of our reprogramming experiment. Presumably, miR-34a regulates reprogramming efficiency largely through a mechanism independent of cell proliferation and cell senescence.
To better define the molecular mechanism of miR-34a in reprogramming, we initiated a search for its targets, specifically by examining genes that promotes the iPSC generation for possible miR-34a-binding sites. RNA22 identified a number of such genes with predicted miR-34a sites 23 ( Supplementary Fig. S5d) . Of all the genes tested, Nanog, Sox2 and Mycn (N-Myc) emerged as top candidates ( Fig. 5a and Supplementary Fig. S5a ). All three exhibited Mir34a-dependent repression ( Fig. 5b and Supplementary Fig. S5c ), and each had potent effects in promoting reprogramming 24, 25 . ESCs over-expressing miR-34a, miR-34b or
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Mature miR-34a p21 miR-34c for 48 h had decreased Nanog, Sox2 and N-Myc protein levels (Fig. 5b ), but unaltered mRNA abundance ( Supplementary Fig. S5b ). This reduction in Nanog, Sox2 and N-Myc protein levels was not due to ESC differentiation, because the level of Oct4, another pluripotency marker, remained unaltered at 48 h post-transfection ( Fig. 5b ). Consistently, levels of Sox2 and Nanog proteins were elevated in Mir34a −/− iPSCs and Mir34a −/− ; Mir34b/c −/− iPSCs when compared with littermate-and passage-controlled wild-type iPSCs (Fig. 5c ). We also observed increased N-Myc levels in Mir34a −/− ; Mir34b/c −/− iPSCs, although this increase was moderate in Mir34a −/− iPSCs ( Fig. 5c and data not shown). Real-time PCR analysis suggested effective silencing of the Sox2 transgene in Mir34a −/− and Mir34a −/− ; Mir34b/c −/− iPSCs ( Supplementary Fig. S3a and data not shown); thus the increased Sox2 level was purely due to alterations in endogenous Sox2. As Oct4 protein levels were largely unchanged among wild-type, Mir34a −/− and Mir34a −/− ; Mir34b/c −/− iPSCs, our data suggest that the increase in Sox2, Nanog and N-Myc was specific for Mir34 deficiency, and not due to differences in iPSC pluripotency (Fig. 5c ). Thus, when Mir34adeficient cells undergo reprogramming, the post-transcriptional derepression of multiple pluripotency genes is likely to promote and accelerate the establishment of the endogenous regulatory circuitry for pluripotency, thereby enhancing reprogramming efficiency.
N-Myc is a previously identified miR-34a target in neuroblastoma cell lines, whose downregulation is mediated through an miR-34abinding site within the 3 untranslated region (UTR; refs 26, 27) . To determine whether miR-34a directly targets Sox2 and Nanog, we constructed luciferase reporters that contained the wild-type 3 UTRs of these genes. Both Sox2 and Nanog 3 UTRs were repressed by exogenous expression of miR-34a in Dicer-deficient HCT116 cells and in wild-type ESCs ( Supplementary Fig. S5c and data not shown); mutation of the miR-34a-binding sites of these reporters significantly compromised miR-34a-dependent regulation ( Supplementary Fig. S5c ). These results indicate that miR-34a directly targets Nanog, Sox2 and N-Myc, thereby impeding iPSC generation. Interestingly, Nanog was previously identified as a direct target of p53-mediated transcriptional repression in multiple stem-cell systems 28, 29 . Thus, p53 mediates Nanog repression both by direct transcriptional silencing and by indirect post-transcriptional silencing through miR-34.
Consistent with the role of miR-34a in negatively regulating multiple pluripotency genes, Mir34a −/− iPSCs exhibited delayed kinetics when triggered to differentiate by leukemia inhibitory factor (LIF) withdrawal, in both the presence and absence of retinoic acid (−LIF and −LIF + RA). Similarly to ESCs, wild-type iPSCs differentiated quickly when subjected to the −LIF or −LIF+RA conditions, as shown by flattened cell morphology and rapid decline of Nanog, Oct4 and Sox2 expression ( Fig. 5d,e ). In contrast, Mir34a −/− iPSCs exhibited significant kinetic delay during differentiation, shown by the slower alterations in morphology and pluripotency-gene expression ( Fig. 5d,e ). In Mir34a −/− iPSCs, the derepression of multiple pluripotency transcription factors may reinforce the regulatory circuitry to maintain self-renewal, causing less efficient silencing of the self-renewal program during differentiation. Conversely, the derepression of pluripotency genes in Mir34a −/− MEFs during reprogramming could promote and accelerate the establishment of the endogenous regulatory circuitry for pluripotency. Our results differ from a recent study where reduced miR-34a function did not impact ESC differentiation 30 . This difference may reflect the limited efficacy of a nucleotide-based miR-34a inhibitor.
Recent studies on gene regulation for pluripotency have focused primarily on transcription-factor profiles. This emphasis may provide an incomplete picture, as post-transcriptional gene regulation by miRNAs could add robust and redundant controls to this process. The small size of miRNAs, combined with their imperfect target recognition, give them enormous capacity and versatility to regulate global gene expression 31 . Along with transcription factors, miRNAs have emerged as essential gene regulators in self-renewal and differentiation of pluripotent stem cells 32, 33 . ESCs with deficient global miRNA biogenesis exhibit proliferation and differentiation defects 34 . In addition, the RNA-binding protein LIN28, which induces reprogramming by suppressing let-7 biogenesis 8,35-37 , has been identified as a major reprogramming factor in humans. Beside let-7 miRNAs, a number of miRNAs are specifically enriched or depleted in pluripotent stem cells and are demonstrated to regulate self-renewal and differentiation 30, 32, 34, [38] [39] [40] . Here, we identify the miR-34 miRNAs as regulators that suppress reprogramming downstream of p53, providing direct evidence that modulation of miRNA abundance could constitute a critical step in establishing pluripotency. As miRNA functions can be manipulated by oligonucleotide-based inhibitors or mimics, our findings suggest a paradigm for promoting reprogramming by manipulating specific miRNA functions. Although p53 directly regulates hundreds of target genes 14 
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Wild type Supplementary Fig. S6 . iPSC induction and reprogramming efficiency. Ecotropic phoenix cells were transfected with the pMX retroviral vectors encoding mouse Oct4, Sox2, c-Myc and Klf4 (Addgene, catalogue nos 13366, 13367, 13375 and 13370) by the calcium phosphate transfection method 43 . One day before infection, MEFs were seeded at 1.3×10 5 cells per well in a six-well plate. MEFs were infected twice, and cultured for 48 h before we sorted 1,000 four-factor-infected MEFs or 2,500 three-factor-infected MEFs into each well of a 12-well plate. Once the iPSC-like colonies appeared, alkaline phosphatase staining or Oct4 staining was carried out to evaluate reprogramming efficiency. To establish stable iPSC lines, single iPSC-like colonies were each picked into one well of a 96-well plate, before expanding on irradiated MEF feeders. To determine reprogramming efficiency using Oct 4-Gfp/+ MEFs, we collected 1,000 four-factor-infected MEFs or 2,500 three-factor-infected MEFs. The reprogrammed iPSC colonies were scored by GFP expression.
To determine if serial transfection of miR-34a LNA inhibitor promotes somatic reprogramming, we transfected miR-34a LNA oligo (Exiqon, catalogue no. 41840-00) and a control LNA oligo (Exiqon, catalogue no. 199004-00) into Oct 4-Gfp/+ MEFs every 6 days during the course of somatic reprogramming. The reprogrammed colonies were scored by GFP-positive clones with characteristic ESC morphology.
Alkaline phosphatase and immunofluorescent staining. Alkaline phosphatase staining was carried out using an Alkaline Phosphatase Detection Kit (Millipore, catalogue no. SCR004) according to the manufacturer's protocol. For immunocytochemical staining, iPSCs were fixed with 4% paraformaldehyde and incubated with blocking solution (0.1%Triton X-100 and 5% normal goat serum in PBS) for 30 min at room temperature. To detect the expression of pluripotency markers, cells were stained with antibody against Oct3/4 (1:100, Santa Cruz Biotechnology, catalogue no. sc-5279), SSEA1 (1:200, Santa Cruz Biotechnology, catalogue no. sc-21702) and Nanog (1:100, Abcam, ab80892). To measure DNA-damage response, wild-type, Mir34a −/− and p53 −/− MEFs infected with four reprogramming factors were collected on days 3, 6 and 9 post-infection. After being fixed with 4% paraformaldehyde, cells were stained with antibody against γ-H2AX (1:200, Millipore, catalogue no. 05-636).
Teratoma formation and chimaera generation. 1 × 10 6 wild-type, Mir34a −/− or Mir34a −/− Mir34b/c −/− iPSCs were injected into dorsal flanks of 6-7-week-old immune-deficient nu/nu mice. Resulting teratomas were fixed in 10% formalin, embedded in paraffin, sectioned to 6 µm and stained with haematoxylin and eosin. To detect differentiated cell types, we stained the cryosection slides with antibody against Tuj1 (1:100, Abcam, cat. no. ab7751), SMA (1:100, Abcam, cat. no. ab18147) and Foxa2 (1:500, Abcam, cat. no. ab40874) to detect cell lineages derived from ectoderm, mesoderm and endoderm, respectively.
To determine the ability of Mir34a −/− iPSCs to contribute to adult chimaeras, we generated Oct 4-Gfp/+, Mir34a −/− , A w /a iPSCs on a mixed C57BL/6 and 129S4Sv/Jae genetic background. Three stable Mir34a −/− iPSC lines were established and injected into albino-C57BL/6/cBrd/cBrd/cr blastocysts at passage 7. Chimeric blastocysts were subsequently transferred to day 2.5 pseudopregnant recipient CD-1 females, and the percentage of chimaera contribution was estimated by scoring the level of coat colour pigmentation.
iPSC differentiation assay. We triggered differentiation of wild-type and Mir34a −/− iPSCs with LIF withdrawal in the presence or absence of retinoic acid 4, 34 .
To remove the feeder cells, iPSCs cultured in the complete media with LIF were trypsinized and plated on 0.1% gelatin-coated plates for 1 h before the collection. Subsequently, feederless iPSCs were plated on gelatin-coated plates in LIF-free media. 1 µM retinoic acid was added to iPSC cultures at day 1. The differentiating iPSCs were collected daily in the course of 4 days, and the expression of pluripotency genes was analysed by real-time PCR. Western analyses. Annealed miR-34a, miR-34b and miR-34c oligos and control siRNA oligos were each transfected into ESCs at a final concentration of 50 nM using Lipofectamine 2000 (Invitrogen, catalogue no. 11668027). 48 h post-transfection, ESCs transfected with miR-34a, miR-34b, miR-34a and control Gfp siRNA, as well as the mock transfected control, were collected into radioimmunoprecipitation assay buffer, 20 mM Tris at pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM EDTA and 0.1% SDS with protease inhibitor cocktail (Roche, catalogue no. 11836153001). Cell lysates were subjected to western analyses. For iPSC collection, trypsinized iPSCs and feeder MEFs were both plated on a gelatin-coated plate. After one hour of culture, feeder MEFs were largely attached to the plates, whereas most iPSCs remained in the supernatant or lightly attached to the MEF feeders. iPSCs were then separated from the feeders, and subjected to western analyses. Antibodies against mouse Nanog (Abcam, ab80892), Sox2 (Millipore, ab5603), Oct3/4 (Santa Cruz, sc-5279), N-Myc (Abcam, ab18698), Klf4 (Abcam, ab26648), p21 (Santa Cruz, sc-6246) and p53 (Vector Laboratories, CM5) were used at 1:1,000 dilution. α-tubulin (Sigma, clone B-5-1-2) was used at a 1:4,000 dilution as a loading control. The quantitation of all western analysis was carried out with Quantity One (Bio-Rad).
Real
Proliferation, apoptosis and senescence assay. Cell proliferation was measured by the cumulative population doublings. For each passage, cells were plated at a concentration of 6 × 10 4 cells per well of a 12-well plate. After every two days of culture, cells were trypsinized, counted and seeded at the same concentration.
To determine the percentage of apoptotic cells in infected MEFs, cells were stained with APC-annexin V (BD Pharmingen, catalogue no. 559925) in 10 mM HEPES at pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 , then incubated with 7-AAD (BD Pharmingen, catalogue no. 550475). The percentages of early-apoptotic cells, late-apoptotic cells and necrotic cells were determined by FACS analysis.
The senescent cells were determined by senescence-associated β-galactosidase (SA-β-Gal) staining. Infected MEFs were fixed in 2% (v/v) formaldehyde and 0.2% (w/v) glutaraldehyde, then stained with freshly prepared staining solution (5 mM K 3 Fe(CN) 6 ; 5 mM K 4 Fe(CN) 6 ; 30 mM citric acid/phosphate buffer, 150 mM NaCl, 2 mM MgCl 2 ; 1 mg ml −1 X-Gal at pH 6.0) at 37 • C for 16-20 h (ref. 46) . The percentages of SA-β-Gal-positive cells were calculated in three independent representative fields, and the total number of cells counted for each measurement exceeded 400. Both WT and mir-34a -/-iPSCs induced by three reprogramming factors expressed pluripotency markers, exhibiting nuclear expression of Oct4 and Nanog, as well as membrane expression of SSEA1. Scale bar, 20mm. e. Three-factor induced WT (left) and mir-34a -/-iPSCs (right) gave rise to terminally differentiated teratomas. H&E staining revealed terminally differentiated tissue types from all three germ layers, including epidermis and neural rosette from ectoderm, cartilage and muscle from mesoderm, and gut-like epithelia and ciliated epithelia from endoderm. Scale bar, 25mm. f. Four-factor-induced Oct4-Gfp/+, mir-34a -/-iPSCs can be maintained in culture for 20 passages without losing the characteristic morphological features (phase-contrast image, left) and Oct4 expression (Oct4-Gfp expression, right). Scale bar, 100mm. g. Representative image of chimeric animals derived from three independent Oct4-Gfp/+, mir-34a -/-iPSC lines. Figure S4 Deficiency of mir-34a does not significantly impair apoptotic response, DNA damage response, and senescence during reprogramming. a. Three-factor transduced WT, mir-34a -/and p53 -/-MEFs were collected before infection and 9 days post-infection. The apoptotic response of each cell line was measured using Annexin-V and 7-amino-actinomycin D (7-AAD) staining. Representative FACS profiles of MEFs with three different genotypes were shown before and after the transduction of three reprogramming factors. b. A quantitative analysis was carried out to compare the percentage of early and late apoptotic populations of each genotype before infection and 9 days after infection. A representative bar graph was shown out of four independent experiments. Although loss of p53 significantly impaired the apoptotic response in three-factor infected MEFs, mir-34a -/-MEFs exhibited no evasion of apoptosis during reprogramming. c. Four-factor transduced WT, mir-34a -/and p53 -/-MEFs were collected six days post-infection, and the DNA damage was measured by the extent of DNA double strand breaks using g-H2AX (red) staining. The nuclei were stained by DAPI (blue). Although loss of p53 significantly impaired the DNA damage response in the four-factor infected MEFs, both WT and mir-34a -/-MEFs exhibited very little g-H2AX staining. Scale bar, 20mm. d. Wildtype, mir-34a -/-, and p53 -/-MEFs were each infected with three reprogramming factors. SA-b-Gal staining was performed 3 days post infection to determine the percentage of senescent population for each genotype. The quantitative analyses were shown for SA-b-Gal staining in MEFs with three different genotypes. Figure S5 The identification of mir-34 targets. a. The predicted miR-34b and miR-34c binding sites in Nanog, Sox2 and N-Myc 3'UTRs by RNA22. miR-34b or miR-34c shared the same seed sequence with miR-34a, and were predicted to bind to the same sites within the 3'UTRs of Nanog and MycN. Interestingly, the predicted miR-34a target site in Sox2 differed from that of miR-34b and c; yet all the predicted miR-34 binding sites contained good seed match and compensatory pairing at the 3' of the mature miRNAs. b. Enforced miR-34 expression did not alter the mRNA level of Nanog, Sox2 and N-Myc. RNAs were prepared from mock transfected ES cells, and those transfected with siGFP, miR-34a, miR-34b and miR-34c, respectively. The levels of Nanog, Sox2 and N-Myc in each sample were determined by real-time PCR analyses 48 hours post transfection. c. Specific repression of Nanog-3'UTR and Sox2-3'UTR reporters by miR-34a. The Nanog and Sox2 3' UTR fragments were each cloned downstream of a luciferase (Luc) reporter (designated as Luc-Nanog-3'UTR and Luc-Sox2-3'UTR, respectively). In addition, we introduced mutations in the corresponding miR-34a binding sites in each reporter to abolish the predicted binding of miR-34a. Luc-Nanog-3'UTR (left) or Luc-Sox2-3'UTR (right) was co-transfected with miR-34a mimics and a control siRNA, siGFP. While miR-34a specifically repressed the expression of both Luc reporters, its co-transfection with the mutated Luc-Nanog-3'UTR or Luc-Sox2-3'UTR reporters exhibited significant derepression of the Luc expression. d. A list of candidate miR-34a targets predicted by RNA22. 
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